World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
Aptose Biosciences to reschedule special meeting
Sharp Therapeutics Provides Update on Non-Brokered Private Placement and Grant of Options
Profound arranges $40-million financing
Ocumetics Technology amends private placement terms
NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis
Glass House applauds U.S. cannabis reform action
Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement
Ocumetics Technology Announces Amendment to Brokered LIFE Offering Led by Centurion One Capital
Glass House Brands Applauds Cannabis Reform Action
Netramark talks Q4 contract backlog
Appili closes $177,500 first tranche of placement
Nxera Pharma to Regain Full Rights to GPR52 Agonist Program for Schizophrenia
Briacell's phase 3 trial gets Nature Medicine spotlight
Knight Therapeutics gets Health Canada OK for Wynzora